Is Novartis Backing Off its Oct. 1 Deadline for 340B Covered Entities? (Update 2)
Note from 340B Report Publisher and CEO Ted Slafsky: I look forward to moderating a panel on the latest 340B developments, President Trump’s drug pricing executive orders, as well as the upcoming elections this Tuesday, Sept. 29 at 12:00 p.m. Eastern. Panelists include Peggy Tighe of 340B Report sponsor Powers Law and Michael McCaughan, Editor of RPM Report. The session will be part of World Congress’s 340B Webinar Series for Covered Entities and Manufacturers. There are four sessions in total. Join for one or all sessions. Registration is free. Click here to register.